Literature DB >> 24792094

ACE overexpression in myelomonocytic cells: effect on a mouse model of Alzheimer's disease.

Maya Koronyo-Hamaoui1, Kandarp Shah, Yosef Koronyo, Ellen Bernstein, Jorge F Giani, Tea Janjulia, Keith L Black, Peng D Shi, Romer A Gonzalez-Villalobos, Sebastien Fuchs, Xiao Z Shen, Kenneth E Bernstein.   

Abstract

While it is well known that angiotensin converting enzyme (ACE) plays an important role in blood pressure control, ACE also has effects on renal function, hematopoiesis, reproduction, and aspects of the immune response. ACE 10/10 mice overexpress ACE in myelomonocytic cells. Macrophages from these mice have an increased polarization towards a pro-inflammatory phenotype that results in a very effective immune response to challenge by tumors or bacterial infection. In a mouse model of Alzheimer's disease (AD), the ACE 10/10 phenotype provides significant protection against AD pathology, including reduced inflammation, reduced burden of the neurotoxic amyloid-β protein and preserved cognitive function. Taken together, these studies show that increased myelomonocytic ACE expression in mice alters the immune response to better defend against many different types of pathologic insult, including the cognitive decline observed in an animal model of AD.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24792094      PMCID: PMC4051235          DOI: 10.1007/s11906-014-0444-x

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  44 in total

Review 1.  Macrophage diversity enhances tumor progression and metastasis.

Authors:  Bin-Zhi Qian; Jeffrey W Pollard
Journal:  Cell       Date:  2010-04-02       Impact factor: 41.582

Review 2.  Alzheimer's disease as proteolytic disorders: anabolism and catabolism of beta-amyloid.

Authors:  T C Saido
Journal:  Neurobiol Aging       Date:  1998 Jan-Feb       Impact factor: 4.673

Review 3.  How to get from here to there: macrophage recruitment in Alzheimer's disease.

Authors:  K Rezai-Zadeh; D Gate; G Gowing; T Town
Journal:  Curr Alzheimer Res       Date:  2011-03       Impact factor: 3.498

4.  Decreased clearance of CNS beta-amyloid in Alzheimer's disease.

Authors:  Kwasi G Mawuenyega; Wendy Sigurdson; Vitaliy Ovod; Ling Munsell; Tom Kasten; John C Morris; Kevin E Yarasheski; Randall J Bateman
Journal:  Science       Date:  2010-12-09       Impact factor: 47.728

5.  Angiotensin-converting enzyme is required for normal myelopoiesis.

Authors:  Chentao Lin; Vivekanand Datta; Derick Okwan-Duodu; Xu Chen; Sebastien Fuchs; Randa Alsabeh; Sandrine Billet; Kenneth E Bernstein; Xiao Z Shen
Journal:  FASEB J       Date:  2010-12-09       Impact factor: 5.191

6.  Angiotensin-converting enzyme overexpression in mouse myelomonocytic cells augments resistance to Listeria and methicillin-resistant Staphylococcus aureus.

Authors:  Derick Okwan-Duodu; Vivekanand Datta; Xiao Z Shen; Helen S Goodridge; Ellen A Bernstein; Sebastien Fuchs; George Y Liu; Kenneth E Bernstein
Journal:  J Biol Chem       Date:  2010-10-11       Impact factor: 5.157

7.  Abeta42-to-Abeta40- and angiotensin-converting activities in different domains of angiotensin-converting enzyme.

Authors:  Kun Zou; Tomoji Maeda; Atsushi Watanabe; Junjun Liu; Shuyu Liu; Ryutaro Oba; Yoh-ichi Satoh; Hiroto Komano; Makoto Michikawa
Journal:  J Biol Chem       Date:  2009-09-22       Impact factor: 5.157

8.  Attenuation of AD-like neuropathology by harnessing peripheral immune cells: local elevation of IL-10 and MMP-9.

Authors:  Maya Koronyo-Hamaoui; Minhee K Ko; Yosef Koronyo; David Azoulay; Akop Seksenyan; Gilad Kunis; Michael Pham; Joshua Bakhsheshian; Patricia Rogeri; Keith L Black; Daniel L Farkas; Michal Schwartz
Journal:  J Neurochem       Date:  2009-09-24       Impact factor: 5.372

9.  Catabolic attacks of membrane-bound angiotensin-converting enzyme on the N-terminal part of species-specific amyloid-beta peptides.

Authors:  Xiaoou Sun; Matthias Becker; Kristin Pankow; Eberhard Krause; Martina Ringling; Michael Beyermann; Bjoern Maul; Thomas Walther; Wolf-Eberhard Siems
Journal:  Eur J Pharmacol       Date:  2008-04-06       Impact factor: 4.432

Review 10.  Angiotensins in Alzheimer's disease - friend or foe?

Authors:  Patrick G Kehoe; Scott Miners; Seth Love
Journal:  Trends Neurosci       Date:  2009-09-30       Impact factor: 13.837

View more
  5 in total

1.  Peripherally derived angiotensin converting enzyme-enhanced macrophages alleviate Alzheimer-related disease.

Authors:  Maya Koronyo-Hamaoui; Julia Sheyn; Eric Y Hayden; Songlin Li; Dieu-Trang Fuchs; Giovanna C Regis; Dahabada H J Lopes; Keith L Black; Kenneth E Bernstein; David B Teplow; Sebastien Fuchs; Yosef Koronyo; Altan Rentsendorj
Journal:  Brain       Date:  2020-01-01       Impact factor: 13.501

Review 2.  Clearance of cerebral Aβ in Alzheimer's disease: reassessing the role of microglia and monocytes.

Authors:  Leah Zuroff; David Daley; Keith L Black; Maya Koronyo-Hamaoui
Journal:  Cell Mol Life Sci       Date:  2017-02-14       Impact factor: 9.261

3.  Identifying drug targets for neurological and psychiatric disease via genetics and the brain transcriptome.

Authors:  Denis A Baird; Jimmy Z Liu; Jie Zheng; Solveig K Sieberts; Thanneer Perumal; Benjamin Elsworth; Tom G Richardson; Chia-Yen Chen; Minerva M Carrasquillo; Mariet Allen; Joseph S Reddy; Philip L De Jager; Nilufer Ertekin-Taner; Lara M Mangravite; Ben Logsdon; Karol Estrada; Philip C Haycock; Gibran Hemani; Heiko Runz; George Davey Smith; Tom R Gaunt
Journal:  PLoS Genet       Date:  2021-01-08       Impact factor: 5.917

4.  Common Impact of Chronic Kidney Disease and Brain Microhemorrhages on Cerebral Aβ Pathology in SHRSP.

Authors:  Daniel Pirici; Luiza Stanaszek; Cornelia Garz; Solveig Niklass; Hans-Jochen Heinze; Thomas Kalinski; Johannes Attems; Stefanie Schreiber
Journal:  Brain Pathol       Date:  2016-05-30       Impact factor: 6.508

5.  ACE gene missense mutation in a case with early-onset, rapid progressing dementia.

Authors:  Jing Ni; Shifu Xiao; Xia Li; Lin Sun
Journal:  Gen Psychiatr       Date:  2019-10-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.